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Summary: An approach is described for using patient databases of a hospital Information System äs a source of
reference values for cardiac enzymes. Of a total of 2029 emergency admission patients with serial cardiac enzyme
data, 538 patients were considered "healthy" (having no damage in myocardium) because their discharge diagnoses
suggested neither myocardial damage nor any other condition that could lead to elevated enzyme activities, and
because their serially collected cardiac enzyme activities remained stable. Enzyme activities of creatine kinase (EC
2.7.3.2), creatine kinase isoenzyme MB, lactate dehydrogenase (EC 1.1.1.28), and lactate dehydrogenase isoenzyme
l of these patients at admission to hospital were considered äs suitable health related reference values. The upper
(97.5%) reference limits of activities, measured at 37 °C according to Scandinavian recommendations, were äs
follows (age dependent limits given at 25 and at 75 years of age, U/l): creatine kinase men 268, 192; creatine
kinase women 200 (no age effect); creatine kinase-MB 16, 24; lactate dehydrogenase 497, 603; lactate dehydroge-
nase isoenzyme l 103, 140. For cpmparison, reference values were also produced conventionally from a group of
246 healthy subjects. Qbserved effects of age on enzyme activities were quite similar to those in the selected patient
group. Calculated reference limits for isoenzymes creatine kinase-MB and lactate dehydrogenase isoenzyme l were
also similar but reference limits for less cardiospecific total enzyme activities, creatine kinase and lactate dehydroge-
nase, were more variable between these two groups. Observed differences in total enzyme activity levels may reflect
different preanalytical conditions of emergency admission patients and conventional reference subjects, in which
case reference values produced from selected "healthy" emergency admission patients would be more suitable for
clinical use. We conclude that reference values can be produced from patient databases with relatively little effort
and at low cost provided that the database Information is clinicälly adequate and reliable.
Introduction " plied in the production of actual clinical laboratory data.
Therefore characteristics of the patient population, like
Production of reference values is an essential fonction distribution and most typical preanalytical condi-
of a clinical laboratory. Usually reference values are pro- ^^ should be investigated before producing reference
duced by prospective data sarnplings of individuals i* yalues The reference population should be selected ac_
presenting the healthy population. For good clinical ap- cording tQ these characteristics.
plicability it is important that the reference individuals
are äs comparable to the patients äs possible, except for Computerised laboratories störe large amounts of data
the considered disease (1). The value of standardizing of laboratory test results. In principle it would be pos-
preanalytical conditions when producing reference val- sible to produce both health- and sickness-related refer-
ues can be questioned if similar Standards cannot be ap- ence values from these databases, if there were enough
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reliable Information for classifying the data in difFerent
diagnostic categories. Information of laboratory test re-
sults and sample collection times are usually readily
available in the laboratory databases. Another available
database in many hospitals is the discharge diagnosis
database, which contains hospital admission and dis-
charge dates, discharge diagnoses and codes of possible
operative therapy. Combination of data from these two
databases is technically possible. It is also possible to do
it without violating patient data security äs all personal
identification data can be removed during the combina-
tion process. We studied the possibilities of using com-
bined database Information äs a source of reference val-
ues for myocardial enzymes. In addition to laboratory
data, clinical discharge diagnoses were available for the
retrospective selection of reference subjects.
Ideally, reference subjects should be äs similar to the
patients äs possible, except for the disease. For labora-
tory diagnosis of myocardial infarction, the first blood
samples are .usually collected at the emergency depart-
ment soon after patient's admission. Emergency admis-
sion patients are emotionally stressed, may have eaten
or may have been physically active just prior to admis-
sion. The time of emergency sample collection is not
standardized with respect to possible diurnal rhythms.
Changes in the above mentioned conditions are known
to affect the serum levels of creatine kinase1) and lactate
dehydrogenase1) (2—5). To meet the demand of sim-
ilarity of preanalytical conditions between patients and
reference subjects, it can be argued that patients hospi-
talised with ehest pain but later proved not to have suf-
fered from myocardial infarction would be ideal refer-
ence subjects. Selection of such patients should be pos-
sible, äs according to several reports only about 20—
30% of all patients suspected of myocardial infarction
at admission to hospital are diagnosed äs such by the
time they are discharged (6—9).
Several aspects must be considered when selecting refer-
ence subjects a posteriori. The registered patient dis-
charge diagnoses stored in patient databases may not be
completely relevant or reliable enough for the selection of
reference subjects (10-13). The fact that also non-myo-
cardial infarction patients with unstable angina may have
microinfarcts and marginal elevations in cardiac markers
(14,15) is another difficulty in the utilisation of discharge
diagnoses for the selection of healthy reference subjects.
We believed that additional criteria not dependent on the
patient diagnoses were needed. As a practical way of
overcoming possible inadequacies in the discharge diag-
!) Enzymes:
Creatine kinase (EC 2.7.3.2), Creatine kinase isoenzyme MB;
Lactate dehydrogenase (EC 1.1.1.28), Lactate dehydrogenase iso-
enzyme l
nosis database, we toök advantage of the available data of
serially collected cardiac enzymes. Follow-up of myocar-
dial markers is known to be among the most sensitive rou-
tinely available means of detecting myocardial damage
(16, 17). Thus, we used changes between serial enzyme
measurements äs an additional selpction criteria for defhi*
ing the patient group with no myocardial damage. The
limits for an acceptable change were obtained from our
previously published data of patients who had no cardiac
Symptoms but who were hospitalised under conditions
comparable to those of patients with ehest pain (18). For
comparison we also produced reference values from a
group of healthy individuals.
Materials and Methods
Healthy reference subjects (n = 246)
For the productipn of health related reference values, blood san>
ples were collected from a grpup of 256 people. Informed consent
was obtained from the individuals in accordance with the ethical
Standards of the Rehabilitation Research Centre of the Social Insur-
ance Institution in Turku and the University Hospital of TYirku.
Reference subjects, who had not used any drugs during the preced-
ing week, were included evenly from ages 27 to 67 years. They
were advised to avoid any physical exertion and cigarette smoking
during the preceding night and any alcohol consumption during the
preceding day. Specimens were collected between 8 and 10 after
an overnight fast, after the subject had been in a sitting position
during the preceding 15 minutes. Ten subjects were excluded from
the reference group for the following reasons: two for being trained
athletes, five for muscular spasms, one for a recent Operation, and
two for macromolecular creatine kinase-BB forms. Öf the rerhain-
ing 246 healthy subjects 128 were men, ages 26 to 67 years (mean
46 years) and 118 women, ages 26 to 67 years (mean 47 years).
Reference change limits ' ·
The hospital admission related reference change limits were ob-
tained from our previously published serial data of 29 noii-cardiac
patients (18). Fifteen of these patients were men, ages 36 to 77
years (mean 58) and 14 women, ages 18 to 73 years (mean 51
years). The homogeneity of within-subject variances was assured
before using the two Standard deviation limits of the distributions
of changes äs reference change limits. These limits were äs fol-
lows: Creatine kinase -42 - 22 U/l, creatine kinase-MB -8
- 8 U/l, lactate dehydrogenase -107 - 91 U/l and lactate dehy-
drogenase isoenzyme l —19 — 12 U/l (18).
Patients
For the retrospective evaluation we included 2029 consecutive
emergency admission patients with an initial suspiqion of rnyo-
cardial infarction or myocarditis and with at least two creatine
kinase determinations on the same or on two consecutive days.
The same patient group was presented in our previous publica-
tion of a method for the caiculation of reference change limits
(18). Of the patients 1192 were men, ages 18 to 92 years (mean
63 years), and 837 were women, ages 26 to 98 years (mean 71
years). The first specimen for cardiac enzyme measurements was
collected at admission to hospital. Serum total creatine kinase
and total lactate dehydrogenase activities were measured in this
sample. The activities of heart specific isoenzymes (creatine
, kinase-MB and lactate dehydrogenase isoenzyme 1) were also
measured, if so requested by the attending physician. At leäst
the creatine kinase activity measureihent was repeated for each
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patient approximately 14 hours after admission, and, according
to clinical judgement, measurements of other enzymes were re-
peated äs well. For the calculation of within-subject changes
between successive measurements, we included the maximum of
three serial samples from the maximum of three consecutive
days.
isoenzyme activity, an electrophoretic Separation of creatine ki-
nase isoenzymes was performed if macromolecular creatine ki-
nase forms were clinically suspected and always if creatine
kinase-MB activity was over 20% of total creatine kinase activ-
ity. Electrophoresis was done in a Corning 720 electrophoretic
device with gel supplied by Corning (Specialgel®, Corning Diag-
nostics Ltd., Halstead, Essex, England).
Selection of "healthy" reference patienfs (n = 538)
In the reference group of 'healthy" patients we only accepted pa-
tients who did not have any "exclusion diagnoses" when they were
discharged from the hospital. Our list of "exclusion diagnoses" in-
cluded all diseases that may have an effect on creatine kinase or
lactate dehydrogenase activities according to citations by Friedman
and Young in "Effects of Disease on Clinical Laboratory Tests",
Washington, AACC Press (1989) (19). Selection of reference pa-
tients according to discharge diagnoses has been previously sug-
gested and used by Kouri et al. (20). An additional exclusion crite-
rion was based on changes between serial cardiac enzyme measure-
ments so that all patients with changes exceeding the reference
change limits were excluded äs well.
Selection of patients wifh angina pectoris (n = 571)
In the reference group of "angina" patients we included all patients
with the discharge diagnosis of angina pectoris. The clinical diag-
nosis of angina pectoris in this hospital is based on the criteria of
the World Health Organisation äs defined for the MONTCA-project
(21). Patients having any other disease with possible effect on cre-
atine kinase or lactate dehydrogenase values were excluded from
this group. Angina patients were further subdivided into two
groups: one with all enzyme changes within reference change lim-
its ("angina(—)" patients) and another with at least one enzyme
change outside reference change limits ("angina(-H)" patients). A
similar division of angina patients into two groups has been pre-
viously used by Boetker et al. (22).
Lactate dehydrogenase assay
Total lactate dehydrogenase activity was determined using a Hi-
tachi 704 or 717 analyser and the Scandinavian-recommended as-
say (25) with reagents made in the laboratory. The between run
CV was 2.2% at 460 U/l.
Lactate dehydrogenase isoenzyme l assay
Lactate dehydrogenase isoenzyme l activity was determined after
immunoprecipitation of the other lactate dehydrogenase isoen-
zymes and subsequent measurement of the remaining lactate dehy-
drogenase activity in a Hitachi 704 or 717 analyser using the pre-
cipitating antibody supplied by Röche (Isomune-LD®, Röche Diag-
nostic Systems, Inc., Nutley, NJ, USA). The other lactate dehydro-
genase reagent was made in the laboratory äs above. The between
run CV was 5.2% at 103 U/l.
The protocol to ensure comparable enzyme activity measurements
on both Hitachi analysers used in our laboratory involves identical
reagents, identical measurement conditions and identical internal
quality control samples at two or three levels. All enzyme activities
were calculated in accordance with the Scandinavian recommenda-
tions (24, 25) using the molar absorptivities of NADH, which were
measured in a Hitachi 704 or 717, using a glucose Standard and
the hexokinase reaction (Gluco-Quant Glucose, Boehringer Mann-
heim, Mannheim, Germany).
Selection of patients with myocardial infarction (n = 471)
In the reference group of "myocardial infarction" patients we in^
cluded all patients with a discharge diagnosis of myocardial infarc-
tion but no other diagnosis possibly affecting creatine kinase or
lactate dehydrogenase values. The foutine diagnosis of myocardial
infarction in this hospital is based on the presence of at least two
of the three criteria defined by the World Health Organisation (23);
these are characteristic ehest päin, unequivocal signs of infarction
in the electrocardiogram, and an observed elevated enzyme activity




Total creatine kinase activity was determined using a Hitachi 704
or 717 analyser (Hitachi Ltd., Tökyö, Japan) and the Scandinavian
recommended assay (24) with reagents supplied by Merck (Diag-
nostica Merck, Inc., Darmstadt, Germany). The between run CV
was 3.4% at 144 U/l.
Creatine kinase-MB assay
Creatine kinase B activity was determined after irnmunoinhibi-
tion of the creatine kinase subunit M activity and subsequent
measurement of the remaining creatine kinase activity in a Hi-
tachi 704 or 717 analyser with reagents supplied by Merck. The
results were rnultiplied by two in order to estimate the creatine
kinase-MB activity. The between run CV was 14.8% at 8.0
U/l. Because this method does not eliminate creatine kinase-BB
Statistical methods
Reference intervals both from the selected patients and from the
healthy reference subjects were calculated äs recommended by the
International Federation of Clinical Chemistry (26). The number of
reference vatues was large enough to study in detäil the effects of
sex, age and their interaction on analyte levels by regression analy-
sis. The data were logarithmically transformed to correct for skew-
ness. If statistically significant (p < 0.05) effects were found, the
data were subgrouped according to sex and/or the effect of age was
taken into accoünt by calculating age-specific reference limits by
regression analysis. The 95% age specific prediction intervals of
logarithmically transformed values were calculated using the
following established formula for prediction of values when the
original data points and the regression function are known (27):
L(Yx) = Yx ± 1.96 · sy, l + + , vvhere
L(YX) is the lower(-) and upper(+) 95% predicted limit for
at a certain age x, Yx is the predicted at age x, sy>x is the
mean Standard deviation of the differences between the observed
y's and the predicted Y's, n is the number of observations and
x is the difference between the observed age and the mean of
all ages of reference subjects. Lower and upper 95% predicted
limits in original scale were obtained after retransformation of
the logarithms.
By this rnethod, age-subgrouping was avoided (28, 29). The Statis-
tical Analysis System® (SAS Institute, Inc., Cary, MC), REFVAL®
(30) and Lotus 1-2-3® (Lotus Development Corp., Cambridge,
MA) Software packages on a microcomputer were used for the data
analysis and graphic presentation.
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Results
Heal thy reference subjects (n = 246)
Table l shows the mean enzyme activities in comparison
with other groups. The subgrouping of healthy reference
subjects shown in table 2 was based on the following
significant (p < 0.05) effects of sex and/or age: for cre-
atine kinase, sex; for lactate dehydrogenase, age and the
interaction of sex and age; for lactate dehydrogenase
isoenzyme l, age. AJthough the interaction of age and
sex was significant for lactate dehydrogenase, the effect
of sex was not significant after considering the age ef-
fect. Consequenüy, gender subgrouping was considered
necessary only for creatine kinase. Activities of lactate
dehydrogenase and lactate dehydrogenase isoenzyme l
increased with age. The coefficients of determination
(R2) of age were 14% for lactate dehydrogenase and
10% for lactate dehydrogenase isoenzyme 1. The age
and sex specific reference limits are shown in table 2.
"Health" related data from selected patients
(n = 538)
Of the 2029 hospital patients, 991 patients (49%) had at
least one exclusion diagnosis and 1253 patients (62%)
had at least one change between consecutive enzyme
measurements that exceeded the reference chahge limit.
Both exclusion criteria were present in 778 patients
(38%). Twenty five patients were excluded because of
macromolecular creatine kinase-BB forms. After all
these exclusion Steps a total of £38 (27%) of the 2029
patients remained in the reference group. Of the patients
287 were men, aged 25 to 90 (mean 63 yeärs), 251
were women aged 29 to 98 (mean 68 years). The
hospital admission enzyme results of these patients
were considered äs suitable "health"-related reference
values.
In the analysis of sex and age effects, we identified the
following significant (p < 0.05) effects: for creatine ki-
nase, sex and the interaction of sex and age; for creatine
kinase-MB, age; for lactate dehydrogenase, age and for
lactate dehydrogenase isoenzyme l, age. Consequently,
gender subgrouping was considered necessary for cre-
atine kinase values. After subgrouping, age had a signifi-
cant effect for creatine kinase values in men but not in
women. The creatine kinase values of men declined with
age until at old age they were almöst similar to those of
women (see fig. 1). Creatine kinase-MB, lactate dehy-
drogenase and lactate dehydrogenase isoenzyme l
Tab. l Mean enzyme activities in different reference groups. For
angina and myocardial infarction patients the mean activities repre-
sent the individual peak values during follow up. All enzyme activ-






















Tab. 2 Age- and sex-specifk health related reference intervals äs
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increased with age (see tab. l and flg. 2). Although the
age effects were statistically significant, the coefficients
of determination (R2) of age were quite low: 4.5% for
creatine kinase-MB, 6.0% for lactate dehydrogenase and
8.7% for lactate dehydrogenase isoenzyme 1. Table 2
shows the age and sex specific reference limits.
Patients with angina pectoris (n = 571)
A total of 899 of the 2029 patients (44%) had a dis-
charge diagnosis of angina pectoris, and 571 angina pec-
toris patient did not have any other diagnoses that would
have affected enzyme values. Of these, 332 patients all
showed changes in their serial cardiac enzyme results
within the reference change limits (angina(—) patients);
whereas 239 patients showed at least one change that
was higher than the respective reference change limit
(angina(-f) patients). The means of peak enzyme activi-
ties of both groups of angina patients are shown in table
l together with data from other groups.
Patients with myocardial infarction (n = 471)
A total of 616 of the 2029 patients (30%) had a dis-
charge diagnosis of acute myocardial infarction. Almost
all (596, 97%) of the myocardial infarction patients had
at least one change outside the reference change limits.
The clinical records of the 20 patients who showed no
enzyme changes beyond the reference change intervals,
and with a discharge diagnosis of myocardial infarction,
were reviewed. This review showed that 5 patients had
suffered myocardial infarction at least 3 days before ad-
mission to hospital and 9 patients at least 2 days after
admission to hospital; for 2 patients a typographical er-
ror had led to an erroneously registered myocardial in-
farction diagnosis; for l patient the autopsy fmdings did
not support the clinical diagnosis of myocardial infarc-
tion; for l patient the clinical records were not available.
For only 2 patients we could retrospectively conftrm that
they had obviously suffered clinically confirmed myo-
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Fig. l Plot of creatine kinase activities in men äs a ftmction of
age in
a) healthy references subjects and in
b) selected healthy" patients.
The lines represent the 2.5th, 50th and 97.5th percentile limits äs
calculated from the logarithmically transformed data. In healthy
reference subjects the age dependency is not statistically significant
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Fig. 2 Plot of lactate dehydrogenase isoenzyme l activities äs a The lines represent the 2.5th, 50th and 97.5th percentile limits äs
function of age in calculated from the logarithmically transformed data. Almost iden-
a) healthy reference subjects and in tical reference limits were obtained from both groups.
b) selected "healthy" patients.
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prior to admission to one day after the admission to hos-
pital, but still did not show enzyme changes exceeding
the reference change limits.
Of the 616 patients with myocardial infarction, 145 were
excluded because they had also some other diagnoses
that could affect creatine kinase or lactate dehydroge-
nase values. The peak enzyme activity values of the re-
maining 471 patients were considered äs myocardial in^·
farction related reference values. Of the patients 315
were men, aged 20 to 89, mean 63 years; 156 were
women aged 42 to 95, mean 72 years. The mean peak
enzyme activities are shown in table l together with re-
sults from other groups.
Discussion
The activities of cardiospecific isoenzymes creatine ki-
nase-MB and lactate dehydrogenase isoenzyme l were
almost identical in retrospectively selected patients and
in the prospective group of healthy reference subjects.
Total creatine kinase activities in selected male patients
were lower than in healthy reference men. The older
mean age of patients at least partly explains this differ-
ence. For emergency admission patients it is often im-
possible to follow procedures for specimen collection
similar to those used when specimens are collected from
the healthy reference subjects. For example muscle exer-
cise or alcohol consumption may affect total lactate de-
hydrogenase by increasing the activity of lactate dehy-
drogenase isoenzyme 4 and lactate dehydrogenase iso-
enzyme 5, which are the predominant lactate dehydroge-
nase isoenzymes in skeletal muscle and liver (4, 5, 31).
These effects would not be seen in lactate dehydroge-
nase isoenzyme l activity. This may also explain our
fmding that total lactate dehydrogenase activities were
higher and showed more Variation in selected "healthy"
patients than in healthy reference subjects, while at the
same time lactate dehydrogenase isoenzyme l activities
were similar in both groups. Also creatine kinase-MB
activities were more similar between the two groups
than total creatine kinase activities. Our observations
support the superiority of cardiospecific isoenzymes
when high signal to noise ratio is desired for the detec-
tion of myocardial damage. For .less cardiospecific
markers it would be especially important to produce ref-
erence values from populations with similar preanalyti-
cal conditions to those of the patients.
The effect of age on enzyme activities was similar in
both retrospective selected patients and in prospective
reference subjects, but some of the statistically signifi-
cant dependencies in the patient group were not signifi-
cant in the prospective group. The latter group did not"
include subjects over 67 years of age, which probably
explains the observed differences in statistical signifi-
cances of age effects.
Lactate dehydrogenase and lactate dehydrogenase isoen-
zyme l increased significantly with age in both groups.
The increase with age in lactate dehydrogenase activities
has also been observed in previbus studies (31). Creatine
kinase in women did not show statistically significant
age-dependency in either of the groups, although
increased creatine kinase activities in postmenopausal
women have been reported previously (31). In the se-
lected patients group, creatine kinase in men decreased
quite markedly with age, while creatine kinase-MB
increased with age in both sexes. The decrease with age
in total creatine kinase activities in men has been re-
ported previously (31), but to our knowledge, age de-
pendency has not been previously described for creatine
kinase-MB or lactate dehydrogenase isoenzyme 1.
The age distribütiön of our prospective healthy reference
group was not completely sätisfactory, äs almost half of
all the clinical results for Interpretation originated from
cardiac patients older than 68 years. The reason for the
tmsatisfactory age distribütiön in this study, äs in many
other reference value studies, was simply that samples
from healthy aged individuals are not easily available.
Definition of health is difficult in old age groups. In the
oldest age groups, completely healthy individuals may
in fact just form a small minority. Mowever, the ob-
served age effects in this study suggest that subjects
older than 67 years should also be included in reference
value collections for cardiac enzymes. The method of
obtaining reference values from patient data gives a so-
lution to this problem.
In the retrospective approach, the production of refer-
ence values resembled the process by which clinicians
gain their practical knowledge öf clinical significance of
laboratory results. A potential source of inaccuracy in
this approach is circular reasoning. Results of the con-
sidered laboratory tests should not be used äs diagnostic
criteria in the selection of reference subjects. We at-
tempted to avoid circular reasoning by using Informa-
tion from two sources: the clinical discharge diagnoses
database, and the laboratory database, inchiding data of
changes between consecutive enzyme meäsürements. If
either of the exclusion criteria applied, the patient was
not accepted äs a healthy reference subject. In spite of
the strict exclusion criteria, the number of remaining ref-
erence subjects was high enough to facilitate the calcula-
tion of age-specific reference limits. The age distribütiön
of selected "healthy" patients was satisfactory. It corre-
sponded to that of all admitted patients.
In about 60% of emergency admission änginä patients,
all enzyme changes were wjjthin respective health re-
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lated reference change intervals (angina(—) patients),
while about 40% of angina patients had at least one
change outside the limits (angina(-f) patients). This ob-
servation and the ratio 3 to 2 is in line with previous
reports (14, 22). Patients with unstable angina and minor
myocardial damage have been found to have an unfa-
vourable short-term prognosis (32). The clinical need to
diagnose such patients Stresses not only the importance
of precise methodology for cardiac markers but also the
importance of accurate health related reference values
and reference change values.
Retrospective selection of myocardial infarction patients
was based solely on the discharge diagnoses. Informa-
tion of the stage of illness or given therapy was not
available in the database. For example, a considerable
Proportion of the patients had received thrombolytic
therapy, but no Information of this nor any other medica-
tion was available in the discharge database. For these
reasons we did not consider the myocardial infarction
related values clinically useful enough to justify the cal-
culation of reference limits for this diagnostic group.
Health related reference values were produced from pa-
tient databases relatively quickly and at low cost. Unfor-
tunately, the missing data of medication and stage of
illness limited the use of databases in the production of
illness related data. Such data would be crucial for the
estimation of optimal clinical decision limits. In the pro-
duction of health related data, the combination of several
selection criteria is possible, which should make the de-
rived values reliable and clinically useful. Large sets of
patient values facilitate the calculation of age and sex
specific reference limits. The effects of variable preana-
lytical conditions, like those related to emergency ad-
mission, are better accounted for by using patient data
äs the source of reference values.
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